Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Feasibility of Controlled Blood-stage Plasmodium Vivax Human Malaria Infection in Healthy Thai Adults
NCT05071079Recruiting
- Sponsor
- University of Oxford
- Start
- May 2022
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Open-label trial (4 arms), sponsored by University of Oxford. Primary endpoints: Incident of treatment-emergent adverse events at 1 year, Optimal inoculation dose at 1 year and 1 more. Started May 2022; status: recruiting.
Beyond the preview
Go deeper on NCT05071079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05071079.